Just 15% of women live for five years if they have been diagnosed with advanced (stage four) endometrial cancer – a cancer ...

Endometrial cancer is the second most prevalent gynecological malignancy. Current standard treatments for endometrial cancer typically include a combination of surgery, radiation therapy and, in some ...

New research predicts a "substantial rise" in uterine cancer cases and deaths in the U.S. through 2050, with Black women most ...

The CDC announced that in 2022, 1,851,238 new cancer cases were reported in the United States ( Americans such as Desiree ...

A recent study highlighted distinct metastatic patterns and survival outcome differences in these 2 cancers, a comparison that may help clinicians better tailor therapy. Cancer Incidence in ...

US patients with metastatic urothelial cancer have seen improvements in survival since ICIs and ADCs have entered the market, data suggest.

FDA designates T-DXd plus pertuzumab as breakthrough therapy for HER2-positive metastatic breast cancer, promising improved survival rates for patients.

According to a 2022 study led by researchers at the National Cancer Institute,deaths from uterine cancer are rising in the U.S., with the highest rates among non-Hispanic Black women.

Endometrial thickness after menopause is one sign of endometrial cancer. Your doctor test to determine this measurement.

Women with preeclampsia in their first pregnancy had a lower risk of developing breast, cervical, and lung cancer later in life, but a higher risk of endometrial cancer. The large Nordic cohort ...

Metastatic prostate cancer is a type of cancer that began in the prostate gland and has spread to other areas of the body, such as distant lymph nodes or bones.